HealthStream (NASDAQ:HSTM) Issues Earnings Results, Beats Expectations By $0.03 EPS

HealthStream (NASDAQ:HSTM) issued its quarterly earnings results on Monday. The technology company reported $0.20 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.17 by $0.03, Zacks reports. HealthStream had a return on equity of 5.70% and a net margin of 6.89%. HealthStream updated its FY 2025 guidance to EPS.

HealthStream Stock Up 2.9%

HealthStream stock traded up $0.72 during trading hours on Monday, reaching $25.32. 237,621 shares of the company’s stock were exchanged, compared to its average volume of 180,832. The firm’s 50 day simple moving average is $27.53 and its 200 day simple moving average is $27.87. HealthStream has a twelve month low of $24.07 and a twelve month high of $34.24. The firm has a market capitalization of $750.51 million, a PE ratio of 37.79, a PEG ratio of 3.08 and a beta of 0.47.

Insiders Place Their Bets

In other HealthStream news, EVP Kevin P. O’hara sold 2,000 shares of the stock in a transaction dated Wednesday, August 27th. The stock was sold at an average price of $27.97, for a total transaction of $55,940.00. Following the completion of the sale, the executive vice president directly owned 17,137 shares in the company, valued at approximately $479,321.89. This trade represents a 10.45% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Insiders own 20.50% of the company’s stock.

Institutional Trading of HealthStream

Large investors have recently made changes to their positions in the company. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its stake in shares of HealthStream by 4.4% in the 2nd quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 103,885 shares of the technology company’s stock valued at $2,874,000 after buying an additional 4,371 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its stake in shares of HealthStream by 15.3% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 54,354 shares of the technology company’s stock valued at $1,749,000 after buying an additional 7,211 shares during the period. American Century Companies Inc. grew its stake in shares of HealthStream by 11.6% in the 2nd quarter. American Century Companies Inc. now owns 58,541 shares of the technology company’s stock valued at $1,620,000 after buying an additional 6,096 shares during the period. Jane Street Group LLC acquired a new stake in shares of HealthStream in the 1st quarter valued at about $1,532,000. Finally, Royal Bank of Canada grew its stake in shares of HealthStream by 194.2% in the 1st quarter. Royal Bank of Canada now owns 43,899 shares of the technology company’s stock valued at $1,413,000 after buying an additional 28,977 shares during the period. 69.58% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of brokerages recently issued reports on HSTM. Canaccord Genuity Group reduced their price target on HealthStream from $29.00 to $28.00 and set a “hold” rating on the stock in a research report on Thursday, August 7th. Weiss Ratings reissued a “hold (c)” rating on shares of HealthStream in a research report on Wednesday, October 8th. One equities research analyst has rated the stock with a Buy rating and three have assigned a Hold rating to the stock. Based on data from MarketBeat, HealthStream currently has an average rating of “Hold” and a consensus target price of $28.00.

About HealthStream

HealthStream, Inc provides Software-as-a-Service (SaaS) based applications for healthcare organizations in the United States. The company’s solutions help healthcare organizations in meeting their ongoing clinical development, talent management, training, education, assessment, competency management, safety and compliance, and scheduling, as well as provider credentialing, privileging, and enrollment needs.